Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Decision Diagnostics

Healthcare US DECN

0.0001USD
0.00(0%)

Last update at 2026-06-18T13:30:00Z

Day Range

0.00010.0001
LowHigh

52 Week Range

0.00010.0001
LowHigh

Fundamentals

  • Previous Close 0.0001
  • Market Cap0.04M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM2.13M
  • Revenue Per Share TTM0.006
  • Gross Profit TTM 0.46M
  • Diluted EPS TTM-0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31
Type yearly yearly yearly yearly yearly
Date 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31
Income before tax -29.66862M -3.13230M -2.24015M -2.98900M -3.17660M
Minority interest - - - - -
Net income -29.66862M -3.13230M -2.24022M -2.99140M -3.18007M
Selling general administrative 2.31M 1.73M 2.63M 2.68M 3.26M
Selling and marketing expenses - - - - -
Gross profit 0.50M 0.85M 0.78M 0.22M 0.25M
Reconciled depreciation - - - - -
Ebit -2.41571M -1.28174M -1.85406M -2.46278M -3.00839M
Ebitda -2.40571M -0.11674M - - -
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -2.10143M -1.29438M -1.85406M -2.46278M -3.00839M
Other operating expenses - - - - -
Interest expense 27.26M 3.02M 0.00000M 0.00000M 0.00000M
Tax provision 0.00273M 0.00000M - - -
Interest income - - - - -
Net interest income -27.26291M -3.01555M - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.00273M - 0.00007M 0.00240M 0.00346M
Total revenue 1.98M 2.38M 2.24M 1.88M 1.09M
Total operating expenses 4.08M 3.67M 4.09M 4.34M 4.10M
Cost of revenue 1.48M 1.53M 1.46M 1.66M 0.85M
Total other income expense net - - -0.38609M -0.52622M -0.16822M
Discontinued operations - - - - -
Net income from continuing ops -29.67135M -3.13230M -2.24022M -2.99140M -3.18007M
Net income applicable to common shares -29.66862M -3.13230M -2.24022M -2.99140M -3.18007M
Preferred stock and other adjustments - - - - -
Breakdown 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31
Type yearly yearly yearly yearly yearly
Date 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31
Total assets 5.65M 5.31M 4.19M 5.13M 6.22M
Intangible assets 3.22M 2.49M 1.72M 1.63M 1.58M
Earning assets - - - - -
Other current assets - - - 0.86M 1.61M
Total liab 5.17M 5.22M 3.09M 3.49M 3.86M
Total stockholder equity 0.48M 0.09M 1.09M 1.64M 2.36M
Deferred long term liab - - - - -
Other current liab 0.24M 0.24M 0.24M 0.24M 0.24M
Common stock 0.35M 0.16M 0.13M 0.11M 0.09M
Capital stock 0.36M 0.16M - - -
Retained earnings -79.39855M -49.72992M -46.59763M -44.35741M -41.36601M
Other liab 0.25M 0.25M 0.25M 0.25M 0.25M
Good will - - - - -
Other assets - - - - -
Cash 0.52M 0.11M 0.36M 1.09M 1.35M
Cash and equivalents - - - - -
Total current liabilities 4.93M 4.97M 2.85M 3.25M 3.62M
Current deferred revenue - - - - -
Net debt 2.40M 2.68M - - -
Short term debt - - - 2.03M 2.30M
Short long term debt 2.93M 2.79M - 2.03M 2.30M
Short long term debt total - - - - -
Other stockholder equity -0.40218M -0.40218M -0.40218M -0.40218M -0.40359M
Property plant equipment 0.80M 0.80M 0.80M 0.80M 0.74M
Total current assets 1.63M 1.33M 1.67M 2.70M 3.91M
Long term investments - - - - -
Net tangible assets -2.74182M -3.08787M -0.62676M 0.01M 0.78M
Short term investments - - - - -
Net receivables 0.94M 1.05M 0.95M 0.44M 0.54M
Long term debt - - - - -
Inventory 0.16M 0.17M 0.25M 0.32M 0.41M
Accounts payable 1.70M 1.25M 1.03M 0.81M 0.72M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.73M 0.68M - - -
Deferred long term asset charges - - - - -
Non current assets total 4.03M 3.98M - - -
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31
Type yearly yearly yearly yearly yearly
Date 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31
Investments 0.05M -0.11638M - - -
Change to liabilities 0.45M 0.22M 0.22M -0.00109M -0.02007M
Total cashflows from investing activities 0.05M -0.11638M -0.09030M -0.11464M -0.32168M
Net borrowings 2.06M 0.69M 0.68M 0.99M 1.87M
Total cash from financing activities 2.06M 0.99M 0.68M 1.41M 3.93M
Change to operating activities -0.28953M 2.67M 0.19M 0.20M 0.65M
Net income -29.66862M -3.13230M -2.24022M -2.99140M -3.18007M
Change in cash 0.71M -0.24442M -0.73000M -0.26310M 0.72M
Begin period cash flow -0.18567M 0.36M - - -
End period cash flow 0.52M -0.18567M 0.36M - -
Total cash from operating activities -1.40497M -1.11467M -1.32295M -1.55892M -2.88134M
Issuance of capital stock - - - - -
Depreciation - - - 0.75M 0.75M
Other cashflows from investing activities - - - -0.04974M -0.01775M
Dividends paid - - - - -
Change to inventory 0.00596M -0.07828M 0.07M -0.00742M -0.64575M
Change to account receivables 0.47M -0.27037M -0.51189M 0.10M -0.41184M
Sale purchase of stock - - - 0.42M 2.14M
Other cashflows from financing activities - - - - -0.07750M
Change to netincome 27.63M -0.62898M 0.20M 0.39M 0.72M
Capital expenditures 0.00000M 0.12M 0.07M 0.06M 0.48M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.64M 2.55M - - -
Stock based compensation - 0.03M - - -
Other non cash items 26.67M 0.45M - - -
Free cash flow -1.40497M -1.23105M - - -

Peer Comparison

Sector: Healthcare Industry: Pharmaceutical Retailers

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
DECN
Decision Diagnostics		 - -% 0.0001 - - 0.02 2.72 1.44 -1.4859
ALBHF
Alibaba Health Information Technology Limited		 - -% 0.42 36.00 19.01 0.36 3.63 1.73 25.72
RADLY
Raia Drogasil SA ADR		 0.06 1.83% 3.33 47.15 32.68 0.34 9.83 0.35 3.29
ALBBY
Alibaba Health Information Technology Limited		 - -% 8.88 34.43 19.84 0.29 3.79 1.73 25.72
SHPPF
Shop Apotheke Europe N.V		 - -% 64.80 - - 2.80 2.28 1.70 78.78

Reports Covered

Stock Research & News

View All

Profile

Decision Diagnostics Corp. develops smart phone based electronic medical record (EMR) technologies. The company offers prescription and non-prescription diagnostics; home testing products for the chronically ill; fulfillment services to direct to patient diabetes programs; and cell phone centric e-health products and technologies development services. It manufactures and distributes GenUltimate! glucose test strips, a Class II medical device for at-home use for the measurement of glucose; PetSure! glucose test strip for the glucose testing of dogs and cats designed to work with the Zoetis AlphaTrak and AlphaTrak II glucometers, a legacy meter; GenUltimate! 4Pets Glucose system, a proprietary glucose measuring system, including GenUltimate! 4Pets test strip and Avantage meter, for the testing of dogs, cats, and horses; and GenUltimate! Sure and GenUltimate! Precis test strips. In addition, it engages in the acquisition and holding of intellectual property including patents and trademarks and specialty manufacturing equipment. Further, the company provides MD@Hand, an inpatient/outpatient management suite; Practice Probe, a data mining utility used to extract information from the physician's practice management system; and ResidenceWare, a residential management system that facilitates the relay of information from commercial and residential real estate management companies to occupying tenants using networking software systems and applications. Its EMR technologies are used by physicians at the point of care. The company was formerly known as InstaCare Corp. and changed its name to Decision Diagnostics Corp. in November 2011. Decision Diagnostics Corp. was founded in 2000 and is based in Westlake Village, California.

Decision Diagnostics

2660 Townsgate Road, Westlake Village, CA, United States, 91361

Key Executives

Name Title Year Born
Mr. Keith M. Berman CEO, CFO, Sec. & Director 1953
Mr. Mark Krakauer Head of Genstrip Private Label Sales Efforts NA
Mr. Chris Knapp Consultant NA
Mr. Keith M. Berman CEO, CFO, Secretary & Director 1953

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions